JPMorgan (JPM.US) Strengthens Core Business, Names New CEO to Lead Tech and Healthcare Investment Banking

JPMorgan Chase (JPM.US) is reshuffling its senior management team for its technology and healthcare investment banking businesses, promoting new leaders in two key areas, according to an internal memo seen by Bloomberg News. The New York-based bank has appointed Pankaj Goel, Madhu Namburi and Drago Rajkovic as global co-heads of technology investment banking, while Mike Gaito will be the global co-head of healthcare, the memo said.The personnel changes underscore the bank's determination to keep its senior talent fresh and competitive in healthcare and technology, two historically active trading areas."Doug Petno and Filippo Gori, co-heads of global banking, said in the memo: "These four new leaders have deep experience within the firm and have been instrumental in the growth of our investment banking business. Our clients and colleagues will benefit from their extensive networks, strategic insights and market expertise."All four new co-heads will report to Petno and Gori.Goel previously served as co-head of technology investment banking in North America, Namburi was global technology head and Rajkovic recently served as vice chairman. Gaito previously was global head of healthcare investment banking.In another memo, JPMorgan announced that Ben Carpenter and Jeremy Meilman were appointed as global co-heads of healthcare investment banking, while Chris Grose and Greg Mendelson were appointed as global co-heads of technology investment banking. They will report to Jay Horine and Dorothee Blessing, co-heads of investment banking.Carpenter will continue to serve as co-head of mergers and acquisitions in North America.A representative for JPMorgan confirmed the authenticity of the memos.